Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
BMJ. 2020 Sep 23;370:m3342. doi: 10.1136/bmj.m3342.
BMJ. 2020.
PMID: 32967856
Free PMC article.